Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Lung Cancer An Emerging Epidemic in the human immunodeficiency virus-Infected Population

Lung Cancer An Emerging Epidemic in the human immunodeficiency virus-Infected Population EDITORIAL Lung Cancer An Emerging Epidemic in the human immunodeficiency virus-Infected Population Alain Makinson, MD,*† Jean-Louis Pujol, MD, PhD,‡ Vincent Le Moing, MD,*† and Jacques Reynes, MD, PhD*† s opportunistic infections and acquired immune deficiency syndrome (AIDS)-related Acancers are decreasing in the human immunodeficiency virus (HIV)-infected popula- tion since the advent of highly active antiretroviral therapy (HAART), new causes of morbidity and mortality are emerging, such as cardiovascular diseases and non-AIDS- 1–4 defining cancers (NADCs). The general aging of the HIV-infected populations in resource-rich settings, because of an increasing life expectancy approaching that of the general population in some successfully treated groups, also explains this shift to 5,6 nonopportunistic diseases. In resource-rich setting studies, lung cancer has the highest 3,7 incidence rate of all NADCs, and despite the advent of HAART, its incidence rate remains increased in comparison with the non-HIV-infected population. The review by Pakkala and Ramalingam focuses on epidemiological, clinical, and management of lung cancers in HIV-infected patients and helps us to disentangle future perspectives of research. This review underscores the increased incidence and the clinical particularities of lung cancer in the HIV-infected population in comparison with the HIV-negative counterparts, including an increased proportion of advanced stages http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Lung Cancer An Emerging Epidemic in the human immunodeficiency virus-Infected Population

Journal of Thoracic Oncology , Volume 5 (11) – Nov 1, 2010

Loading next page...
 
/lp/wolters-kluwer-health/lung-cancer-an-emerging-epidemic-in-the-human-immunodeficiency-virus-oF6C8htK6I

References (29)

ISSN
1556-0864
DOI
10.1097/JTO.0b013e3181f7c78f
pmid
20975371
Publisher site
See Article on Publisher Site

Abstract

EDITORIAL Lung Cancer An Emerging Epidemic in the human immunodeficiency virus-Infected Population Alain Makinson, MD,*† Jean-Louis Pujol, MD, PhD,‡ Vincent Le Moing, MD,*† and Jacques Reynes, MD, PhD*† s opportunistic infections and acquired immune deficiency syndrome (AIDS)-related Acancers are decreasing in the human immunodeficiency virus (HIV)-infected popula- tion since the advent of highly active antiretroviral therapy (HAART), new causes of morbidity and mortality are emerging, such as cardiovascular diseases and non-AIDS- 1–4 defining cancers (NADCs). The general aging of the HIV-infected populations in resource-rich settings, because of an increasing life expectancy approaching that of the general population in some successfully treated groups, also explains this shift to 5,6 nonopportunistic diseases. In resource-rich setting studies, lung cancer has the highest 3,7 incidence rate of all NADCs, and despite the advent of HAART, its incidence rate remains increased in comparison with the non-HIV-infected population. The review by Pakkala and Ramalingam focuses on epidemiological, clinical, and management of lung cancers in HIV-infected patients and helps us to disentangle future perspectives of research. This review underscores the increased incidence and the clinical particularities of lung cancer in the HIV-infected population in comparison with the HIV-negative counterparts, including an increased proportion of advanced stages

Journal

Journal of Thoracic OncologyWolters Kluwer Health

Published: Nov 1, 2010

There are no references for this article.